After the Decision No. 78 of the Board Eurasian Economic Commission (EEC) on November 3rd, 2016, the “Rules” for registration and expert review of drugs for medical use within the Eurasian Economic Union (EAEU) were approved and entered into force…
❄ Season’s greetings and Happy New Year ! This year BlueReg is proud to make a contribution to the foundation Abbé Pierre to support their work in helping homeless people worldwide. The Foundation Abbé Pierre is present all over…
The French regulation on the prevention and management of stock shortages of medicinal products is part of the European legal framework defined by Directive 2001/83/EC, one article of which (81) establishes the principle of the responsibility of manufacturers and distributors…
There is a high demand around the need for antibody testing and the media frenzy surrounding the subject shows it is clear there is a poor understanding of what type of test is useful, how the test can be qualified,…
The purpose of the Bill is to replace the EU Human Medicines Directive, which will expire in 2021 at the end of the transition period agreed between the UK and EU The Bill will collate the existing regulatory powers…